keyword
MENU ▼
Read by QxMD icon Read
search

pericarditis guidelines

keyword
https://www.readbyqxmd.com/read/28873222/uremic-pericarditis-pericardial-effusion-and-constrictive-pericarditis-in-end-stage-renal-disease-insights-and-pathophysiology
#1
REVIEW
Karim Abdur Rehman, Jorge Betancor, Bo Xu, Arnav Kumar, Carlos Godoy Rivas, Kimi Sato, Leslie P Wong, Craig R Asher, Allan L Klein
A rising prevalence of end-stage renal disease (ESRD) has led to a rise in ESRD-related pericardial syndromes, calling for a better understanding of its pathophysiology, diagnoses, and management. Uremic pericarditis, the most common manifestation of uremic pericardial disease, is a contemporary problem that calls for intensive hemodialysis, anti-inflammatories, and often, drainage of large inflammatory pericardial effusions. Likewise, asymptomatic pericardial effusions can become large and impact the hemodynamics of patients on chronic hemodialysis...
September 5, 2017: Clinical Cardiology
https://www.readbyqxmd.com/read/28675268/-news-about-pericardial-diseases-in-2016
#2
Baris Karpuz, Valèrie Duchatelle, Maxime Tapponnier, Raluca Alexe, Christophe Sierro, Grègoire Girod
The European Society of Cardiology published in 2015 the new Guidelines on the management of pericardial diseases. Based on experts' opinions and recent clinical studies of respectable size, the new guidelines thoroughly revisit the criteria for hospitalization and precisely define severe cases. Another highlight regards medication. From now, first-line medical therapy should include the association of colchicine to the traditional non steroidal anti-inflammatory drugs or aspirin. The bi-therapy is recommended as soon as the first episode of pericarditis, for duration of 3 months...
September 7, 2016: Revue Médicale Suisse
https://www.readbyqxmd.com/read/28660191/the-therapeutic-role-of-interleukin-1-inhibition-in-idiopathic-recurrent-pericarditis-current-evidence-and-future-challenges
#3
George Lazaros, Katerina Antonatou, Dimitrios Vassilopoulos
Recurrent pericarditis is a common complication of acute pericarditis (15-30%) for which, in most cases, no underlying etiology is found [idiopathic recurrent pericarditis (IRP)]. IRP is currently viewed as an autoinflammatory disease with characteristic recurrent episodes of sterile inflammation. According to the most recent Guidelines, the initial treatment regimen consists of a combination of aspirin or non-steroidal anti-inflammatory drugs with colchicine followed by the addition of corticosteroids in resistant or intolerant cases...
2017: Frontiers in Medicine
https://www.readbyqxmd.com/read/28407841/cardiovascular-comorbidity-in-inflammatory-rheumatological-conditions
#4
Jürgen Braun, Klaus Krüger, Bernhard Manger, Matthias Schneider, Christof Specker, Hans Joachim Trappe
BACKGROUND: Approximately 1.5 million adults in Germany suffer from an inflammatory rheumatological condition. The most common among these are rheumatoid arthritis and spondyloarthritis-above all axial spondyloarthritis, including ankylosing spondylitis (Bekhterev's disease) and psoriatic arthritis. These systemic inflammatory diseases often affect the heart as well. METHODS: This review is based on pertinent articles retrieved by a selective literature search, on current European guidelines, and on the authors' clinical experience...
March 24, 2017: Deutsches Ärzteblatt International
https://www.readbyqxmd.com/read/28357026/novel-noninvasive-nuclear-medicine-imaging-techniques-for-cardiac-inflammation
#5
REVIEW
Malte Kircher, Constantin Lapa
PURPOSE OF REVIEW: Inflammation is a key player in a wide range of cardiovascular and myocardial diseases. Given the numerous implications of inflammatory processes in disease initiation and progression, functional imaging modalities including positron emission tomography (PET) represent valuable diagnostic, prognostic, and monitoring tools in patient management. Since increased glucose metabolism is a hallmark of inflammation, PET using the radiolabeled glucose analog [(18)F]-2-deoxy-2-fluoro-d-glucose (FDG) is the mainstay diagnostic test for nuclear imaging of (cardiac) inflammation...
2017: Current Cardiovascular Imaging Reports
https://www.readbyqxmd.com/read/28214508/surgical-management-of-pericardial-diseases
#6
REVIEW
Douglas R Johnston
Disease of the pericardium represents a relatively rare indication for cardiac surgery, and there exist no widely accepted guidelines for surgical management. As such, the surgical approach to the pericardium has relied largely on institutional experience with a slow evolution based on published studies. In particular, management of pericardial constriction has varied widely from surgeon to surgeon and institution to institution, in large part due to a perception of inherent high risk to the procedure. This review covers the current practice of surgery for disease of the pericardium, with particular focus on the evolution of indications for pericardiectomy, new applications in inflammatory or relapsing pericarditis, and the progressive refinement in surgical technique and operative planning which have led to significantly improved outcomes in experienced centers...
January 2017: Progress in Cardiovascular Diseases
https://www.readbyqxmd.com/read/28079270/treatment-of-adults-with-idiopathic-recurrent-pericarditis-novel-use-of-immunotherapy
#7
REVIEW
Nicholas C Schwier, Genevieve M Hale, Marie L Davies
Idiopathic recurrent pericarditis (IRP) can be challenging to treat. Even after guideline-directed first-line treatment consisting of aspirin (ASA) or a nonsteroidal antiinflammatory drug (NSAID) in combination with colchicine therapy, recurrences still occur in greater than 20% of patients. Many patients then require treatment with long-term corticosteroids, which is not a favorable option due to their short- and long-term adverse effects. Because it is theorized that the pathophysiology of IRP may possess autoimmune sequelae, the use of immunotherapy for the treatment of IRP has emerged...
March 2017: Pharmacotherapy
https://www.readbyqxmd.com/read/27965998/a-prospective-investigation-into-the-effect-of-colchicine-on-tuberculous-pericarditis
#8
RANDOMIZED CONTROLLED TRIAL
Jurgens Jacobus Liebenberg, Catherine Jane Dold, Lourens Rasmus Olivier
INTRODUCTION: Tuberculous (TB) pericarditis carries significant mortality and morbidity rates, not only during the primary infection, but also as part of the granulomatous scar-forming fibrocalcific constrictive pericarditis so commonly associated with this disease. Numerous therapies have previously been investigated as adjuvant strategies in the prevention of pericardial constriction. Colchicine is well described in the treatment of various aetiologies of pericarditis. The aim of this research was to investigate the merit for the use of colchicine in the management of tuberculous pericarditis, specifically to prevent constrictive pericarditis...
November 2016: Cardiovascular Journal of Africa
https://www.readbyqxmd.com/read/27909473/cryoablation-for-the-treatment-of-drug-refractory-symptomatic-atrial-fibrillation-a-regional-medical-center-experience
#9
Robert Tonks, Hiba Tul Kareem Sayed, Ashley Adams, William T Smith
INTRODUCTION: PVI is an effective, guideline-based treatment for drug refractory symptomatic AF. Balloon cryoablation has been shown to be a safe and effective method for PVI. In the STOP-AF trial, data was produced from practitioners performing PVI with significant experience at high volume centers. This study evaluates the effectiveness and safety of treating symptomatic, drug refractory AF with PVI via cryoablation after implementation in a regional medical center. METHOD: This represents a retrospective analysis of outcomes after cryoablation treatment for AF in 71 patients over 354...
February 2016: Journal of Atrial Fibrillation
https://www.readbyqxmd.com/read/27701691/-update-on-pericardial-diseases
#10
REVIEW
Joachim Seichter, Bernhard Schieffer
In 2015, an updated version of the ESC guidelines on pericardial diseases was published. The new guidelines summarize findings in the area of etiology, diagnosis and therapy of pericardial diseases and introduce an algorithm to diagnose pericarditis. Additionally, criteria for hospital submission were introduced. The use of multimodal imaging procedures was emphasized and medical as well as interventional therapy strategies were adapted to current knowledge.
September 2016: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/27163900/pericardial-hyperechogenicity-and-comets-in-patients-with-acute-pericarditis-but-no-pericardial-effusion-a-comparison-study-with-age-matched-healthy-controls
#11
Daniele Sartorio, Carmine Siniscalchi, Claudio Reverberi, Nicola Gaibazzi
BACKGROUND AND AIM: According to the published data and guidelines the diagnosis of pericarditis is mainly clinical; if we exclude patients with pericardial effusion, no single study has been able to relate specific echocardiographic findings to acute pericarditis. We hypothesized that pericardial hyperechogenicity and a defined finding that we named "pericardial comets", in analogy to lung comets, may be associated with acute pericarditis. METHODS: We retrospectively analysed the echocardiograms of patients aged <50 y/o with a confirmed pericarditis diagnosis and compared them with 2 prospectively healthy controls groups (either < or > 50 y/o) to detect a potential association of pericardial hyperechogenicity and/or pericardial comets with acute pericarditis...
2016: Acta Bio-medica: Atenei Parmensis
https://www.readbyqxmd.com/read/27150501/frequency-and-factors-associated-with-inappropriate-for-intervention-cardiac-catheterization-laboratory-activation
#12
Apurva Patel, Roosha Parikh, Kanhaiya L Poddar, Stephen G Ellis, E Murat Tuzcu, Samir R Kapadia
BACKGROUND: Current guidelines emphasize timely coronary intervention with a door to balloon time of ≤90min for favorable survival impact after STEMI. Efforts to achieve these targets may result in unnecessary emergent angiography for inappropriate activations. OBJECTIVE: Evaluate the frequency, trend and factors which are significantly associated with inappropriate for intervention cardiac catheterization laboratory (CCL) activation. METHODS: We analyzed 1764 consecutive emergent CCL activation for possible ST segment elevation myocardial infarction (STEMI) between 7/2005 and 8/2013...
June 2016: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://www.readbyqxmd.com/read/27007597/european-guidelines-on-pericardial-diseases-a-focused-review-of-novel-aspects
#13
REVIEW
Alexander Fardman, Philippe Charron, Massimo Imazio, Yehuda Adler
Pericardial diseases are not uncommon in daily clinical practice. The spectrum of these syndromes includes acute and chronic pericarditis, pericardial effusion, constrictive pericarditis, congenital defects, and neoplasms. The extent of the high-quality evidence on pericardial diseases has expanded significantly since the first international guidelines on pericardial disease management were published by the European Society of Cardiology in 2004. The clinical practice guidelines provide a useful reference for physicians in selecting the best management strategy for an individual patient by summarizing the current state of knowledge in a particular field...
May 2016: Current Cardiology Reports
https://www.readbyqxmd.com/read/26985483/-diagnosis-and-admission-criteria-updated-new-guideline-pericarditis
#14
Philipp Grätzel
No abstract text is available yet for this article.
October 22, 2015: MMW Fortschritte der Medizin
https://www.readbyqxmd.com/read/26853248/summary-2015-esc-guidelines
#15
REVIEW
Guy Van Camp, Agnes Pasquet, Peter Sinnaeve, Georges H Mairesse, Michel De Pauw, Marc J Claeys
No abstract text is available yet for this article.
February 2016: Acta Cardiologica
https://www.readbyqxmd.com/read/26742476/usefulness-of-novel-immunotherapeutic-strategies-for-idiopathic-recurrent-pericarditis
#16
REVIEW
Dor Lotan, Yishay Wasserstrum, Alexander Fardman, Michael Kogan, Yehuda Adler
Idiopathic recurrent pericarditis (IRP) is a debilitating illness which leads to great suffering and multiple hospitalizations. Management of acute pericarditis and subsequent recurrences has evolved significantly as the use of colchicine-based strategies become more prevalent, yet there still remains a subset of patients who remain refractory to colchicine therapy, and these patients require prolonged corticosteroid (CS) therapy for the control of symptoms. Since the 1960s, there have been reports of successful management of these cases with immunosuppressive therapy...
March 1, 2016: American Journal of Cardiology
https://www.readbyqxmd.com/read/26691443/pericardial-disease-a-clinical-review
#17
REVIEW
Syed Wamique Yusuf, Saamir A Hassan, Elie Mouhayar, Smita I Negi, Jose Banchs, Patrick T O'Gara
Pericardial disease is infrequently encountered in cardiovascular practice, but can lead to significant morbidity and mortality. Clinical data and practice guidelines are relatively sparse. Early recognition and prompt treatment of pericardial diseases are critical to optimize patient outcomes. In this review we provide a concise summary of acute pericarditis, constrictive pericarditis and pericardial effusion/tamponade.
2016: Expert Review of Cardiovascular Therapy
https://www.readbyqxmd.com/read/26667949/-2015-esc-guidelines-for-the-diagnosis-and-management-of-pericardial-diseases-task-force-for-the-diagnosis-and-management-of-pericardial-diseases-of-the-european-society-of-cardiology-esc
#18
Yehuda Adler, Philippe Charron, Massimo Imazio, Luigi Badano, Gonzalo Baron-Esquivias, Jan Bogaert, Antonio Brucato, Pascal Gueret, Karin Klingel, Christos Lionis, Bernhard Maisch, Bongani Mayosi, Alain Pavie, Arsen D Ristic, Manel Sabaté Tenas, Petar Seferovic, Karl Swedberg, Witold Tomkowski
No abstract text is available yet for this article.
December 2015: Giornale Italiano di Cardiologia
https://www.readbyqxmd.com/read/26644393/-progress-or-regress-or-both-esc-guidelines-on-pericardial-diseases-2015
#19
B Maisch
Eleven years after the publication of the first guidelines worldwide on pericardial diseases by the European Society of Cardiology (ESC), the international expert group of the ESC has updated the original document of 28 pages with 275 references. The final version of the new guidelines is more voluminous with 44 pages of recommendations but only 233 references. A continuing medical education (CME) certified update of the 2004 guidelines was published in the journal Herz volume 7/2014. In comparison to 2004 the 2015 guidelines have remained virtually unchanged in the sections detailing diagnostics, differential diagnosis, pathology and pathophysiology...
December 2015: Herz
https://www.readbyqxmd.com/read/26050223/recurrent-constrictive-pericarditis-a-diagnostic-and-therapeutic-challenge
#20
Raquel Ferreira, Anabela Gonzaga, Luís Santos, José António Santos
Recurrent right-sided heart failure after pericardiectomy may be caused by incomplete pericardiectomy, recurrent constriction, diastolic dysfunction or myocardial involvement. Identifying recurrent constrictive pericarditis (CP) in patients who have recurring symptoms after pericardiectomy is challenging, since the characteristic Doppler echocardiographic features may not be present if a portion of the ventricles are free of constricting pericardium, and there are no diagnostic or treatment guidelines for management of recurrent CP...
June 2015: Portuguese Journal of Cardiology: An Official Journal of the Portuguese Society of Cardiology
keyword
keyword
120829
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"